| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Cytotherapy | 2006 | 11K |
| MicroRNA signatures in human cancers | Nature Reviews Cancer | 2006 | 6.3K |
| Oncomirs - microRNAs with a role in cancer | Nature Reviews Cancer | 2006 | 5.9K |
| Cancer statistics, 2006 | Ca-A Cancer Journal for Clinicians | 2006 | 4.6K |
| Fibroblasts in cancer | Nature Reviews Cancer | 2006 | 3.4K |
| Population structure and eigenanalysis | PLoS Genetics | 2006 | 3K |
| Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world | Journal of Clinical Oncology | 2006 | 2.8K |
| Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Cancer Cell | 2006 | 2.6K |
| A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes | Cancer Cell | 2006 | 2.4K |
| Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial | Lancet Oncology, The | 2006 | 2.3K |
| Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Cancer Cell | 2006 | 2.3K |
| The global health burden of infection-associated cancers in the year 2002 | International Journal of Cancer | 2006 | 2.1K |
| mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt | Cancer Research | 2006 | 2.1K |
| Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer | Journal of Clinical Oncology | 2006 | 2K |
| Drug penetration in solid tumours | Nature Reviews Cancer | 2006 | 2K |
| International uniform response criteria for multiple myeloma | Leukemia | 2006 | 2K |
| Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference | International Journal of Radiation Oncology Biology Physics | 2006 | 1.9K |
| Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer | Nature Reviews Cancer | 2006 | 1.9K |
| KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer | Cancer Research | 2006 | 1.9K |
| Photodynamic therapy and anti-tumour immunity | Nature Reviews Cancer | 2006 | 1.8K |
| The NCI60 human tumour cell line anticancer drug screen | Nature Reviews Cancer | 2006 | 1.8K |
| Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines | Cancer Cell | 2006 | 1.8K |
| Introduction to NF-kappaB: players, pathways, perspectives | Oncogene | 2006 | 1.7K |
| Paradoxical roles of the immune system during cancer development | Nature Reviews Cancer | 2006 | 1.7K |
| Distinct role of macrophages in different tumor microenvironments | Cancer Research | 2006 | 1.7K |
